Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia

Haematologica 2026 Open access

Read full text
Authors: Liyan Fan, Li Gao, Wen Zhang, Linhai Yang, Hongjun Liu, Hongsheng Wang, Peifang Xiao, Ning Liao, Yong Zhuang, Xueju Xu, Jixia Luo, Yeting He
+14 more Yuan Zhang, Xue Han, Yixin Hu, Jie Li, Hailong He, Y H Wang, Cheng Cheng, Xiaowen Zhai, Xiuli Ju, Ningling Wang, Jun Lu, Hua Jiang, R C Ribeiro, Shaoyan Hu
DOI: 10.3324/haematol.2025.289170
Cited by: 0

Abstract

No standard salvage regimen exists for relapsed/refractory (R/R) pediatric AML. In this prospective, multicenter Phase II trial, 101 evaluable patients (.

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Acute Lymphoblastic Leukemia research

Publication details

Journal / source
Haematologica
Publication date
5 February 2026
Language
EN